Addiction
|
OPPORTUNITY NUMBER |
OPPORTUNITY TITLE |
AGENCY NAME |
POSTED DATE |
CLOSE DATE |
|
HEAL Initiative: Exploratory Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R21- Clinical Trial Not Allowed) |
HHS-NIH11 |
12/20/2021 |
03/10/2022 | |
|
HEAL Initiative: Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R01- Clinical Trial Not Allowed) |
HHS-NIH11 |
12/20/2021 |
03/10/2022 | |
|
Rigorous Evaluation of Strategies to Prevent Overdose through Linking People with Illicit Substance Use Disorders to Recovery Support Services |
HHS-CDC-HHSCDCERA |
12/20/2021 |
03/14/2022 | |
|
Understanding Polydrug Use Risk and Protective Factors, Patterns, and Trajectories to Prevent Drug Overdose |
HHS-CDC-HHSCDCERA |
12/20/2021 |
02/24/2022 | |
|
HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required) |
HHS-NIH11 |
11/16/2021 |
02/11/2022 | |
|
NIH HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 Clinical Trials Optional) |
HHS-NIH11 |
11/16/2021 |
03/02/2022 | |
|
Using Just-in-Time Adaptive Interventions to Optimize Established Adolescent Mental Health Treatments (R61/R33 Clinical Trial Required) |
HHS-NIH11 |
11/15/2021 |
02/22/2023 | |
|
Grants to Support New Investigators in Conducting Research Related to Understanding Polydrug Use Risk and Protective Factors |
HHS-CDC-HHSCDCERA |
11/08/2021 |
01/07/2022 | |
|
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) |
HHS-NIH11 |
09/02/2021 |
09/08/2024 | |
|
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) |
HHS-NIH11 |
03/26/2021 |
03/08/2024 |
|
|
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) |
HHS-NIH11 |
11/16/2020 |
11/15/2023 |
|
|
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional) |
HHS-NIH11 |
11/16/2020 |
11/15/2023 |
|
|
Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Use and Addiction Scientists (R25 Clinical Trials Not Allowed) |
HHS-NIH11 |
10/27/2020 |
11/15/2023 |
|
|
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01) |
HHS-NIH11 |
09/29/2020 |
10/31/2023 |
|
|
New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 - Clinical Trial Optional ) |
HHS-NIH11 |
08/28/2020 |
08/11/2023 |
|
|
New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial Required) |
HHS-NIH11 |
08/28/2020 |
08/11/2023 |
|
|
NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) |
HHS-NIH11 |
07/17/2020 |
11/17/2022 |
|
|
Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional) |
NIH |
10/18/2019 |
11/07/2022 |
|
|
NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) |
NIH |
04/23/2019 |
01/07/2022 |
|
|
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) |
NIH |
03/07/2019 |
03/23/2022 |
|
|
Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) |
NIH |
03/07/2019 |
03/23/2022 |